Article Listing - US market developments in 2002-3 and the rise of generics; CBI meeting

MOMENTUM OF 1991 CONTINUES AT SB

27 April 1992

The momentum achieved by Anglo-American pharmaceutical company SmithKline Beecham in 1991 is continuing in 1992, the company's results for the...

PROCTER & GAMBLE PHARMACEUTICALS

27 April 1992

Norwich Eaton has now taken the name Procter and Gamble Pharmaceuticals. The change, according to company, is a sign of...

FORTHCOMING MEETINGS

27 April 1992

- Management Forum is organizing two round table meetings to be held in London: Schizophrenia: Recent Advances in Aetiology and...

CANADA APPROVES INTERFERON ALFA

27 April 1992

The sale of two new products to treat patients infected with the hepatitis B virus has been approved in Canada....

SHILEY FDA LETTER "UNNECESSARY"

27 April 1992

The Shiley Heart Valve Research Center has called "unnecessary" a letter issued by the Public Citizen Health Research Group that...

ISRAELI INDUSTRY FACES PRICE PRESSURE

27 April 1992

In Israel, there have been demands that Hevrat Haovdim and the General Sick Fund, both...

US FDA SLAMMED FOR "GUERILLA WAR" TACTICS

27 April 1992

We are now witnessing the emergence of a period of fundamentalist regulation and enforcement at the US Food and Drug...

CPMP MEETING DECISIONS

27 April 1992

At a recent meeting of the European Community's Committee for Pro-prietary Medicinal Products, four multi-state and nine concertation (eight variations)...

POST-ELECTION OUTLOOK FOR UK HEALTH SECTOR

20 April 1992

The UK Health and Household sector looks set to continue its period of consolidation and to underperform the stock market...

GEHE SALES AND PROFITS grow IN 1991

20 April 1992

German Drug manufacturer Gehe made group sales in 1991 of just over 5 billion Deutschemarks ($3 billion), an increase of...

Showing 94171-94180 of 95341 articles